3-(BETA-D-RIBOFURANOSYL)-7-(4-CHLOROPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE
Compound with spectra: 1 NMR
![3-(BETA-D-RIBOFURANOSYL)-7-(4-CHLOROPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE](/api/compound/HY1tR1NQt6H.png?ph=true&h=300&w=458 "3-(BETA-D-RIBOFURANOSYL)-7-(4-CHLOROPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE")
| SpectraBase Compound ID | HY1tR1NQt6H |
|---|---|
| InChI | InChI=1S/C17H15ClN2O6S/c18-8-3-1-7(2-4-8)9-6-27-14-11(9)19-17(25)20(15(14)24)16-13(23)12(22)10(5-21)26-16/h1-4,6,10,12-13,16,21-23H,5H2,(H,19,25)/t10-,12-,13-,16-/m1/s1 |
| InChIKey | JYNFPEPXQRPIRT-XNIJJKJLSA-N |
| Mol Weight | 410.83 g/mol |
| Molecular Formula | C17H15ClN2O6S |
| Exact Mass | 410.033935 g/mol |
| Enantiomer InChIKey | JYNFPEPXQRPIRT-SDPXSBNPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
3-(BETA-D-RIBOFURANOSYL)-7-(4-FLUOROPHENYL)-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE
3-(BETA-D-RIBOFURANOSYL)-7-PHENYL-THIENO-[3,2-D]-PYRIMIDINE-2,4-DIONE
1-[(3aR,4R,6R,6aR)-2,2-dimethyl-6-methylol-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-6-[[tert-butyl(diphenyl)silyl]oxymethyl]pyrimidine-2,4-quinone
11,15-DIACETOXY-14-OXO-CYATHIN-A3
6-[(tert-Butyldiphenylsilanoxy)methyl]-5'-deoxy-2',3'-O-isopropylideneuridine 5'-oxo
2-{[[3-(Biphenyl-3-yl)-1-phenyl-1H-pyrazol-4-yl]methylene]-hydrazono}-3-(.beta.-D-glucopyranosyl)-4-phenyl-2,3-dihydrothiazole
2-Methyl-1-(3',4'-dimethoxyphenyl)-6-(N-methylanilino)-2H-isoindole-4,7-dione
Aquilarabietic acid I
N-cyclohexyl-2-({2-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-8,9-dimethoxy[1,2,4]triazolo[1,5-c]quinazolin-5-yl}sulfanyl)acetamide
METHYL-(METHYL-5-ACETAMIDO-4,7,8-TRI-O-ACETYL-9,10-DIDEHYDRO-3,5,9,10-TETRADEOXY-10-METHOXYCARBONYL-D-GLYCERO-D-GALACTO-2-DECULOPYRANOSID)-ONATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of thieno[3,2-d]pyrimidine-2,4-diones cyclic and acyclic nucleosides as potential anti HIV agents | Journal of Heterocyclic Chemistry | 1994 |